Marijuana receptor Might Hold The Key to Fertility Treatments For Men
Research has been carried out to show how CB2 – a cannabinoid receptor – can determine the amount of sperm that is produced. It is additional proof that the use of marijuana can affect the fertility of men.
Research has been carried out to show how CB2 – a cannabinoid receptor – can determine the amount of sperm that is produced. It is additional proof that the use of marijuana can affect the fertility of men. It also intimates that there is a way to treat male infertility.
It is estimated that 15% of couples are affected by infertility across the world. Out of these, up to 70% are male based. This is information from researcher Paola Grimaldi Ph.D., who is based at the University of Rome Tor Vergata, Italy.
Scientists suggest that cannabis exposure may affect DNA-bound proteins, sperm chromatin and have an impact on fertility, embryo development and offspring health.
The initial tests were carried out on mice, and they were treated with different agents for between 14 and 21 days. The first ones were given a CB2 activator. In the second group, a different agent was used. Mice were given an inhibitor of a CB2 receptor. For the third group of mice, it was a saline solution only that was provided and these were just the control group.
There was a noticeable acceleration of spermatogenesis in the mice that had been treated with the CB2 activator, and the opposite occurred with the second group. The rate slowed here and it showed that the inhibitor did have an effect on the process. For spermatogenesis to progress properly there has to be a clear and tight balance when it comes to the activation of CB2.
Editor in Chief of the FASEB Journal Thoru Pedersen is pleased that this is a new chemical way to treat male infertility.
Source: Federation of American Societies for Experimental Biology
Related Coverage
- Researchers Discover Ground Ice on the Protoplanet Vesta
- Dark Matter of the Human Genome Offers Insight as to How the Androgen Receptor Impacts Prostate Cancer
- Scientists Take Control of The Key Protein to Stop The Spread of Stifles Cancer
- Immigrants Have Been Founded 51% of U.S. Billion-Dollar Startups
- How Climate Change Will Affect What We Eat?
Don't miss new tech stories on Google
Add TrendinTech once in the Google app and our stories appear in your news suggestions.
Helena Marsh
Helena Marsh is the Editor-in-Chief at TrendinTech, where she leads editorial strategy and oversees coverage across artificial intelligence, cybersecurity and enterprise technology. With more than a decade in technology journalism on both sides of the Atlantic, she previously served as a senior editor at Wired UK and covered the technology sector for The Guardian, following the rise of the big platforms, the Cambridge Analytica scandal and the regulatory push from Brussels and Washington. Helena holds an MA in Journalism from City, University of London and is a regular speaker at Web Summit in Lisbon and CES in Las Vegas. She believes technology reporting should be rigorous and plainly written, so readers understand what actually changes for them rather than what a company's announcement promises.
All stories by Helena Marsh (201)